351 completed, 36 recruiting, 23 unknown, 22 terminated. 365 Phase 1, 46 Phase 2, 22 Not applicable, 20 Phase 3, 16 Phase 4.
Follow this drug Literature Review of Itraconazole trials Research Report on Itraconazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants Clifutinib, Itraconazole, fluconazole - Healthy Adult Subject | Phase 1 | Not yet recruiting | Sunshine Lake Pharma Co., Ltd. | 80 | 2026-12-31 | 2026-04-27 |
| A Study of Itraconazole and Posaconazole for Chronic Pulmonary Aspergillosis Posaconazole Delayed Release Oral Tablet, Itraconazole (ITZ) - Chronic Pulmonary Aspergillosis | Phase 3 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 220 | 2026-11-01 | 2026-10-01 |
| A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11 TBD11 (300 mg), Placebo, Itraconazole (200 mg) - Healthy Adult Participants | Phase 1 | Not yet recruiting | Gates Medical Research Institute | 66 | 2026-10-16 | 2026-10-20 |
| Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 60 | 2026-10-01 | 2026-06-30 |
| Effect of a Known P-glycoprotein (P-gp) Inhibitor, Itraconazole, on the Pharmacokinetics (PK) of Engasertib Engasertib, Itraconazole - Healthy Participants | Phase 1 | Active not recruiting | Vaderis Therapeutics AG | 27 | 2026-09-18 | 2026-10-15 |
| A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy Adults Itraconazole, Rifampicin, Omeprazole - Healthy Subjects | Phase 1 | Not yet recruiting | InventisBio Co., Ltd | 60 | 2026-09-16 | 2026-10-15 |
| A Drug-drug Interaction Study to Assess the Effect of Phenytoin and Itraconazole on the Pharmacokinetics of Pelabresib in Healthy Participants Pelabresib, Phenytoin, Itraconazole - Healthy Participants | Phase 1 | Recruiting | Novartis Pharmaceuticals | 30 | 2026-09-02 | 2026-09-22 |
| Drug-Drug Interaction Study of Vorolanib Tablets in Healthy Participants vorolanib and rifampicin, vorolanib and itraconazole - DDI (Drug-Drug Interaction) | Phase 1 | Recruiting | Betta Pharmaceuticals Co., Ltd. | 36 | 2026-09-01 | 2026-09-09 |
| A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood BI 3000202, Ciclosporin, Itraconazole - Healthy | Phase 1 | Active not recruiting | Boehringer Ingelheim | 16 | 2026-09-01 | 2026-10-13 |
| Drug-Drug Interaction Study of Befotertinib Capsules in Healthy Participants. Befotertinib and rifampicin, Befotertinib and itraconazole - DDI (Drug-Drug Interaction) | Phase 1 | Recruiting | Betta Pharmaceuticals Co., Ltd. | 36 | 2026-09-01 | 2026-09-09 |
| A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants Navlimetostat, Itraconazole, Rifampin - Healthy Female Adults | Phase 1 | Recruiting | Bristol-Myers Squibb | 80 | 2026-08-31 | 2026-10-05 |
| A Study of RO7890597 in Healthy Adult Volunteers RO7890597, Placebo, Rabeprazole - Healthy Volunteers | Phase 1 | Recruiting | Genentech, Inc. | 139 | 2026-08-28 | 2026-10-16 |
| A Trial of Lu AH69593 in Healthy Participants Lu AH69593, Itraconazole, Carbamazepine - Healthy Participants | Phase 1 | Recruiting | H. Lundbeck A/S | 46 | 2026-08-27 | 2026-10-14 |
| A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder ABBV-932, Itraconazole - Bipolar Disorder | Phase 1 | Recruiting | AbbVie | 20 | 2026-08-20 | 2026-09-16 |
| Itraconazole Therapy In Bronchiectasis With Airway Mold Itraconazole 200 mg - Bronchiectasis, Fungal Infection of Upper Respiratory Tract | Phase 4 | Recruiting | Mayo Clinic | 30 | 2026-08-17 | 2026-08-21 |
| A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504 HS-10504, Itraconazole Capsules - Healthy Participants | Phase 1 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 8 | 2026-08-01 | 2026-08-14 |
| Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants AZD4144, Itraconazole - Healthy | Phase 1 | Recruiting | AstraZeneca | 32 | 2026-07-30 | 2026-09-28 |
| A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021) MK-8527, Probenecid, Itraconazole - Healthy | Phase 1 | Active not recruiting | Merck Sharp & Dohme LLC | 44 | 2026-06-30 | 2026-09-03 |
| A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants Nacresertib, Itraconazole - Healthy Volunteer | Phase 1 | Active not recruiting | AbbVie | 12 | 2026-06-23 | 2026-09-18 |
| Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus Biopsy Procedure, Biospecimen Collection, Endoscopic Procedure - Barrett Esophagus, Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 76 | 2026-06-23 | 2026-09-14 |
Showing 20 of 462. Sign in to see all of them.
HIV Infections (12) · Neoplasms (12) · Carcinoma, Non-Small-Cell Lung (10) · Acquired Immunodeficiency Syndrome (9) · Breast Neoplasms (9) · Mycoses (8) · Aspergillosis (7) · Histoplasmosis (7) · Neoplasm Metastasis (7) · Recurrence (7) · Aspergillosis, Allergic Bronchopulmonary (6) · Hematologic Neoplasms (6) · Leukemia, Myeloid, Acute (6) · Onychomycosis (6) · Prostatic Neoplasms (6)
Boehringer Ingelheim (24) · Pfizer (23) · AstraZeneca (19) · Eli Lilly and Company (14) · Bristol-Myers Squibb (12) · Post Graduate Institute of Medical Education and Research, Chandigarh (10) · Bayer (9) · AbbVie (8) · Celgene (7) · Genentech, Inc. (7) · GlaxoSmithKline (7) · Hoffmann-La Roche (7) · Merck Sharp & Dohme LLC (7) · Janssen Research & Development, LLC (6) · Jiangsu HengRui Medicine Co., Ltd. (6)
United States (220) · China (66) · United Kingdom (39) · Germany (38) · Belgium (21) · South Korea (17) · Australia (16) · Canada (15) · Japan (13) · Spain (13) · France (11) · Netherlands (11) · India (10) · Pakistan (10) · Italy (8)
PMID 22606232, PMID 24493717, PMID 12729424, PMID 14964746, PMID 1542320, PMID 18791359, PMID 19240154, PMID 19734776, PMID 19968146, PMID 20395554, PMID 20701787, PMID 20739853, PMID 20881067, PMID 20979469, PMID 20979472, PMID 21319349, PMID 21422405, PMID 21623265, PMID 21767331, PMID 21789167, PMID 21933749, PMID 22088989, PMID 22463890, PMID 22469884, PMID 22563440, PMID 22565425, PMID 22895351, PMID 22954507, PMID 23099620, PMID 23150682, PMID 23303450, PMID 23340005, PMID 23373662, PMID 23496375, PMID 23511841, PMID 23546045, PMID 23724914, PMID 23884486, PMID 24009246, PMID 24079585, PMID 24128715, PMID 24298851, PMID 24352873, PMID 24593273, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25211297, PMID 25264305, PMID 25514427
2018 (10), 2016 (8), 2014 (7), 2017 (7), 2015 (6), 2019 (6), 2023 (5), 2025 (2), P50GM060338 (2), I01CX002349 (1), P30CA046592 (1), P30CA124435 (1), R01GM056687 (1), UG1CA242632 (1)